Boise Cascade Company
—- Market cap
- —
- Debt
- —
- Cash
- −$477.22M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: BCC stock price vs BRKR: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BRKR's multiple
Needs BRKR P/E.
Implied fair value · at BCC's multiple
Needs Annual EPS is negative, BCC P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Boise Cascade Company · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
BRUKER CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
WEYERHAEUSER CO
BCC vs WY
TEMPUR SEALY INTERNATIONAL, INC.
BCC vs TPX
LOUISIANA-PACIFIC CORP
BCC vs LPX
TREX CO INC
BCC vs TREX
THERMO FISHER SCIENTIFIC INC.
BCC vs TMO
DANAHER CORP /DE/
BCC vs DHR
AGILENT TECHNOLOGIES, INC.
BCC vs A
WATERS CORP /DE/
BCC vs WAT
BIO-RAD LABORATORIES, INC.
BCC vs BIO
BIO-TECHNE Corp
BCC vs TECH
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe BCC can defend its low-margin earnings and remain near current profitability while BRKR’s leverage and earnings volatility persist, then BCC is the better relative-value choice because it combines a much lower P/S and EV/EBITDA with stronger profitability and balance-sheet metrics.
BCC trades at 0.4x P/S and 10.8x EV/EBITDA versus BRKR at 2.7x P/S and 33.6x EV/EBITDA, indicating a very large relative discount for BCC. However, BRKR’s negative net income and extremely high negative P/E make earnings-based comparison noisy, while the provided implied price of $489.53 suggests a model output that is far above both the current price and the historical trading band.
Supporting Metrics